Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

Background and aim The International Cancer of the Pancreas Screening Consortium met in 2018 to update its consensus recommendations for the management of individuals with increased risk of pancreatic cancer based on family history or germline mutation status (high-risk individuals). Methods A modified Delphi approach was employed to reach consensus among a multidisciplinary group of experts who voted on consensus statements. Consensus was considered reached if ≥75% agreed or disagreed. Results Consensus was reached on 55 statements. The main goals of surveillance (to identify high-grade dysplastic precursor lesions and T1N0M0 pancreatic cancer) remained unchanged. Experts agreed that for those with familial…

• S
  Sanofi
• BS
  Boston Scientific Corporation
• CM
  Cook Medical
• HF
  Hope Foundation
• M
  Mylan
• LW
  Living With Hope Foundation
• NI
  National Institutes of Health

  Award: U01CA210170
• NC
  National Cancer Institute

  Award: CA210170